Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diffusion capacity and static hyperinflation as markers of disease progression predict 3-year mortality in COPD: Results from COSYCONET.
Pott H, Weckler B, Gaffron S, Martin R, Maier D, Alter P, Biertz F, Speicher T, Bertrams W, Jung AL, Laakmann K, Heider D, Wouters M, Vogelmeier CF, Schmeck B; COSYCONET Study Group. Pott H, et al. Among authors: gaffron s. Respirology. 2024 Oct 24. doi: 10.1111/resp.14843. Online ahead of print. Respirology. 2024. PMID: 39448064 Free article.
Differential Response to 12 Weeks of Once-Daily Tiotropium/Olodaterol Fixed Dose Combination in Patients with COPD: A Multidimensional Response Profiling in the TORRACTO Study.
Posthuma R, Vanfleteren LEGW, Gaffron S, Vaes AW, Franssen FME, Spruit MA. Posthuma R, et al. Among authors: gaffron s. Int J Chron Obstruct Pulmon Dis. 2023 Jun 8;18:1091-1102. doi: 10.2147/COPD.S405478. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37313498 Free PMC article.
Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study.
Koopman M, Franssen FME, Gaffron S, Watz H, Troosters T, Garcia-Aymerich J, Paggiaro P, Molins E, Moya M, van Burk L, Maier D, Garcia Gil E, Wouters EFM, Vanfleteren LEGW, Spruit MA. Koopman M, et al. Among authors: gaffron s. Int J Chron Obstruct Pulmon Dis. 2022 Mar 8;17:517-533. doi: 10.2147/COPD.S308600. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35342289 Free PMC article. Clinical Trial.
Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients.
Augustin IML, Franssen FME, Houben-Wilke S, Janssen DJA, Gaffron S, Pennings HJ, Smeenk FWJM, Pieters WR, Hoogerwerf A, Michels AJ, van Merode F, Wouters EFM, Spruit MA. Augustin IML, et al. Among authors: gaffron s. PLoS One. 2022 Feb 17;17(2):e0263657. doi: 10.1371/journal.pone.0263657. eCollection 2022. PLoS One. 2022. PMID: 35176055 Free PMC article. Clinical Trial.
Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members.
Vaes AW, Goërtz YMJ, Van Herck M, Machado FVC, Meys R, Delbressine JM, Houben-Wilke S, Gaffron S, Maier D, Burtin C, Posthuma R, van Loon NPH, Franssen FME, Hajian B, Simons SO, van Boven JFM, Klok FA, Spaetgens B, Pinxt CMH, Liu LYL, Wesseling G, Spies Y, Vijlbrief H, van 't Hul AJ, Janssen DJA, Spruit MA. Vaes AW, et al. Among authors: gaffron s. ERJ Open Res. 2021 May 24;7(2):00141-2021. doi: 10.1183/23120541.00141-2021. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 34041295 Free PMC article.
Comorbidity clusters in patients with moderate-to-severe OSA.
Testelmans D, Spruit MA, Vrijsen B, Sastry M, Belge C, Kalkanis A, Gaffron S, Wouters EFM, Buyse B. Testelmans D, et al. Among authors: gaffron s. Sleep Breath. 2022 Mar;26(1):195-204. doi: 10.1007/s11325-021-02390-4. Epub 2021 May 3. Sleep Breath. 2022. PMID: 33942208
16 results